Evidence map›Paper›PMID 41502757›Full record

ArticleACS omega2025

Tumor-Targeting T

Ying Liu, Tirusew Tegafaw, Ahrum Baek, Son Long Ho, Dejun Zhao, Xiaoran Chen, Endale Mulugeta, Hansol Lee, Hyunji Nam, Jihyun Kim and 2 more

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ying LiuDepartment of Chemistry, College of Natural Sciences, Kyungpook National University, Daegu 41566, South Korea.ORCID https://orcid.org/0009-0008-2826-6536
Tirusew TegafawDepartment of Chemistry, College of Natural Sciences, Kyungpook National University, Daegu 41566, South Korea.
Ahrum BaekInstitute of Biomedical Engineering Research, School of Medicine, Kyungpook National University, Daegu 41944, South Korea.ORCID https://orcid.org/0000-0002-6941-8259
Son Long HoDepartment of Chemistry, College of Natural Sciences, Kyungpook National University, Daegu 41566, South Korea.ORCID https://orcid.org/0000-0001-7175-246X
Dejun ZhaoDepartment of Chemistry, College of Natural Sciences, Kyungpook National University, Daegu 41566, South Korea.ORCID https://orcid.org/0009-0002-0785-049X
Xiaoran ChenDepartment of Chemistry, College of Natural Sciences, Kyungpook National University, Daegu 41566, South Korea.
Endale MulugetaDepartment of Chemistry, College of Natural Sciences, Kyungpook National University, Daegu 41566, South Korea.ORCID https://orcid.org/0000-0002-2869-0934
Hansol LeeDepartment of Medical & Biological Engineering, Kyungpook National University, Daegu 41944, South Korea.
Hyunji NamDepartment of Medical & Biological Engineering, Kyungpook National University, Daegu 41944, South Korea.
Jihyun KimDepartment of Chemistry Education, Teachers' College, Kyungpook National University, Daegu 41566, South Korea.ORCID https://orcid.org/0000-0002-5119-6627
Yongmin ChangDepartment of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu 41944, South Korea.ORCID https://orcid.org/0000-0002-0585-8714
Gang Ho LeeDepartment of Chemistry, College of Natural Sciences, Kyungpook National University, Daegu 41566, South Korea.ORCID https://orcid.org/0000-0001-7451-6366

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polydopamine (pdop) and polyserotonin (pser) can target tumor cells through their conjugation with dopamine (dop)- and serotonin (ser)-receptors overexpressed on tumor cells. In this study, pdop- or pser-conjugated poly-(acrylic acid) (PAA)-grafted gadolinium oxide nanoparticles (denoted as pdop-PAA-Gd

Identifiers

PMID41502757
PMCPMC12771183

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.